[1] Stocker K, Fisher H, Meier J, et al. Characterization of the protein C activator Protac from the venom of the southem copperhead (Agkistrodon contortrix) snake[J]. Toxicon, 1987, 25(3): 239-243. [2] Klein JD, Walker FJ. Purification of a protein C activator from the venom of the southern copperhead snake (Agkistrodon contortrix) [J]. Biochemistry, 1986, 25(15): 4175-4179. [3] Kogan AE, Makarow AN, Bobruskin ID, et al. Comparative study of protein C activators from the Agkistrodon snake venoms[J]. Thromb Res, 1991, 62(6): 775-780. [4] 符民桂, 管锦霞. 蛇毒蛋白C活化剂的研究进展[J]. 国外医学输血及血液学分册, 1996, 19(6): 367- 369. [5] Strukova SM, Kogan AE, Tara A, et al. Anticoagulant effect of the protease from Agkistrodon venom mediated by protein C activation in rats[J]. Thromb Res, 1989, 55(1): 149-153. [6] 张根葆, 陈冬云, 周志泳, 等. 蝮蛇毒蛋白C激活物的纯化与抗血小板活性[J]. 皖南医学院学报, 2005, 24(1): 8-10. [7] 孔岩, 张根葆, 李曙, 等. 蝮蛇蛇毒PCA对实验性心肌梗死大鼠血凝状态的影响[J]. 皖南医学院学报, 2009, 28(5): 316-318. [8] 李曙, 张根葆. 蝮蛇毒蛋白C激活物对大鼠在体心肌缺血再灌注损伤的干预作用[J]. 皖南医学院学报, 2008, 27(3): 167-169. [9] 袁伯俊, 廖明阳, 李波. 药物毒理学实验方法与技术[M]. 北京: 化学工业出版社, 2007: 200-210. [10] EPA OPPTS. Harmonized Test Guideline 870. 1100 Acute Oral Toxicity[S]. 1998. [11] OECD. Guidelines for the testing of chemicals. Guideline 425: Acute oral toxicity-up-and-down procedure [S]. 2001: 1-26. [12] SFDA. 化学药物急性毒性试验技术指导原则[S]. GPT1-1. 2005. [13] Rispin A, Farrar D, Macgosches E, et al. Alternative methods for the median lethal dose (LD(50)) test: the up-and-down procedure for acute oral toxicity[J]. ILAR J, 2002, 43(4): 233-243. [14] 包丽丽, 张根葆, 张世. 心肌缺血及再灌注大鼠血浆蛋白C活性变化的实验研究[J]. 中国临床药理学与治疗学, 2010, 15(9): 1012-1015. [15] 李佳, 金晶, 黄芝瑛. 上下法在急性毒理试验中的应用进展[J]. 中国比较医学杂志, 2008, 18(6): 70-72. |